Union Health Ministry’s timely intervention ensured in mitigating the effects of the corona pandemic.
The Ministry has time and again taken several measures to communicate correct and verified information to the citizens.
In an attempt to resolve several queries related to the COVID vaccination programme, the Centre used all possible mediums to reach out to the people and dispel all related myths.
AIR correspondent takes a look at one such frequently asked question by people with regard to the concern about amount of antibody generated by the COVID vaccines.
Director at All India Institute of Medical Sciences , AIIMS New Delhi, Dr. Randeep Guleria has said that efficacy of vaccines should not be judged only by the amount of antibodies they are able to generate in the body.
He informs that in addition to antibodies, Vaccines help in boosting immunity against specific infections through multiple other ways.
Dr. Guleria has said that like many other vaccines, COVID Vaccines also develop cell-mediated immunity and immunity through memory cells.
These memory cells help generate more antibodies in case a person gets infected at a later stage.
Dr. Guleria affirmed that data available till now shows clearly that efficacy of all vaccines – whether COVAXIN, COVISHIELD or Sputnik V – are more or less equivalent.
Therefore he suggests to take whichever jab is available at the earliest and not pick , choose or wait for vaccine of preference.
Convenor of Empowered Group for National Vaccination programme Dr. V K Paul has also asserted that antibody test is not the right choice to judge the quality of immunity gained through the vaccination.
He has strongly advised everyone to take the jabs including those who got infected and have successfully recovered from COVID-19.